Cilostazol Matches Double-Dose Clopidogrel Following PCI
March 26, 2012|Internal Medicine News
Author and Disclosure Information
FROM THE ANNUAL MEETING OF THE AMERICAN COLLEGE OF CARDIOLOGY
Dr. Kim said he had no relevant financial disclosures. Dr. Ohman said that he has been a consultant to a wide variety of pharmaceutical companies, including Sanofi-Aventis, Merck, Bristol-Myers Squibb, AstraZeneca, and Boehringer Ingelheim. He has received research support from Eli Lilly, Maquet, and Daiichi Sankyo. Dr. Stone said that he has also been a consultant to a variety of pharmaceutical companies. Dr. Dangas said that he has been a consultant to AstraZeneca and has received research grants from Sanofi-Aventis, Bristol-Myers Squibb, Eli Lilly, and Daiichi Sankyo.
